New Insights into Cerebral Vessel Disease Landscapes at Single-Cell Resolution: Pathogenetic and Therapeutic

Megi Meneri1,2, Sara Bonato3, Delia Gagliardi1,2

  • 1Dino Ferrari Centre, Department of Pathophysiology and Transplantation (DEPT), University of Milan, 20122 Milan, Italy.

Biomedicines
|July 27, 2022
PubMed

Insights

Single-cell RNA sequencing reveals cellular details of cerebrovascular diseases. This technology helps identify new therapeutic targets for conditions like stroke and vascular dementia by analyzing immune responses in blood and vessel cells.

Area of Science:

  • Biomedical Science
  • Genomics
  • Cardiovascular Research

Background:

  • Cerebrovascular diseases are a major global health concern, causing significant death and disability.
  • Current therapeutic target development is hindered by incomplete understanding of the cellular and molecular basis of these diseases.

Purpose of the Study:

  • To explore the utility of omics technology, specifically RNA sequencing, for studying cerebrovascular diseases.
  • To investigate cellular heterogeneity and molecular mechanisms in diseased cerebral vessels at single-cell resolution.

Main Methods:

  • Utilized single-cell RNA sequencing to analyze high-dimensional profiles of individual blood and vessel cells.
  • Applied RNA sequencing in animal models to track cellular alterations in atherosclerotic plaques.
  • Employed single-cell transcriptomics in humans to map molecular and cellular levels of cerebral artery plaques.

Main Results:

  • Dissected the heterogeneity of diseased cerebral vessels, including atherosclerotic plaques, microenvironment, cell trajectory, and immune responses.
  • Tracked individual cells (immune, endothelial, smooth muscle) in animal models and their changes during plaque development.
  • Mapped human cerebral artery plaques at molecular and cellular levels, identifying specific immune cells like lymphocytes and macrophages.

Conclusions:

  • Single-cell RNA sequencing provides unprecedented resolution for studying cerebrovascular disease mechanisms.
  • This approach aids in identifying novel immune targets for therapeutic intervention in stroke and vascular dementia.
  • Multi-omics single-cell technologies promise to generate precise cellular signatures for tailored cerebrovascular disease treatments.

Related Concept Videos